Has Edward Ray, MD received payments from drug or device companies?

Yes. Drug and device makers reported $30,643 in general payments to Edward Ray, MD across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edward Ray, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edward Ray, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edward Ray, MD

Plastic and Reconstructive Surgery · West Hollywood, CANPI 1184808438

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (36.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Pfizer at 36.2% of the total. 2025 is the largest year on record at $19,994, more than ten times the $524 reported in 2019. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,643in general payments, 2019–2025

Across 124 payments — averaging $247.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$11K
Johnson & Johnson$7K
Sientra, Inc.$5K
RTI Surgical, Inc$2K
Integra Lifesciences Corporation$2K
Polynovo North America LLC$1K
plus $3K from 14 others

$30,905in research payments, 2019–2025

Across 2 payments — averaging $15,453 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$31K

What the payments were for

Consulting fees$8,53028%
Speaking & faculty fees$11,10036%
Travel & lodging$1,6245%
Food & beverage$9,39031%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	3	$11,100
Johnson & Johnson	4	$7,332
Sientra, Inc.	42	$4,711
RTI Surgical, Inc	8	$1,862
Integra Lifesciences Corporation	8	$1,723
Polynovo North America LLC	23	$1,391
TELA Bio, Inc.	6	$859
AbbVie(2 entities)	10	$464
Mentor Worldwide LLC	6	$271
Musculoskeletal Transplant Foundation Inc.	2	$235
Davol Inc.	1	$155
Innovation Technologies Inc	1	$98
Tepha Inc	2	$84
Olympus America Inc.	1	$81
Biocircuit Technologies Inc	1	$63
Medical Microinstruments, Inc.	2	$58
Antares Pharma, Inc.	1	$50
BD	1	$40
Vioptix Inc	1	$35
Baxter Healthcare	1	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XTANDI$11,100
SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$3,777
CORTIVA ALLOGRAFT DERMIS$1,735
SURGIMEND$1,500
CODMAN CERTAS$1,180
OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$645
INTEGRA$639
OMNIGRAFT$320
INTEGRA DERMAL REGENERATION TEMPLATE$320
Novosorb BTM$272
OviTex 2S$172
Phasix Mesh$155
DuraSorb Monofilament Mesh$143
NATRELLE$129
NATRELLE SALINE-FILLED BREAST IMPLANTS$124
CORTIVA TAILORED ALLOGRAFT DERMIS$110

How this compares

$30,643 in reported general payments places this provider in the 90th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California →

Medicare billing

Part B allowed, 2024

$77,799

Medicare patients

Services billed

202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in West Hollywood

Philip BrazioWest Hollywood$22K
William BrunoWest Hollywood$12K
Mark SuskiThousand Oaks$294K
Corey MaasSan Francisco$286K
Arian MowlaviLaguna Beach$250K
Charles LeeSan Francisco$200K
David SieberSan Francisco$195K
David KulberLos Angeles$194K
Matthew NykielUpland$181K
Subhas GuptaLoma Linda$178K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →